Literature DB >> 29802127

Human Naive T Cells Express Functional CXCL8 and Promote Tumorigenesis.

Joel Crespo1,2, Ke Wu1,3, Wei Li1,3, Ilona Kryczek1, Tomasz Maj1, Linda Vatan1, Shuang Wei1, Anthony W Opipari4, Weiping Zou5,2,6,7,8.   

Abstract

Naive T cells are thought to be functionally quiescent. In this study, we studied and compared the phenotype, cytokine profile, and potential function of human naive CD4+ T cells in umbilical cord and peripheral blood. We found that naive CD4+ T cells, but not memory T cells, expressed high levels of chemokine CXCL8. CXCL8+ naive T cells were preferentially enriched CD31+ T cells and did not express T cell activation markers or typical Th effector cytokines, including IFN-γ, IL-4, IL-17, and IL-22. In addition, upon activation, naive T cells retained high levels of CXCL8 expression. Furthermore, we showed that naive T cell-derived CXCL8 mediated neutrophil migration in the in vitro migration assay, supported tumor sphere formation, and promoted tumor growth in an in vivo human xenograft model. Thus, human naive T cells are phenotypically and functionally heterogeneous and can carry out active functions in immune responses.
Copyright © 2018 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29802127      PMCID: PMC6039239          DOI: 10.4049/jimmunol.1700755

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  34 in total

Review 1.  Immunosuppressive networks in the tumour environment and their therapeutic relevance.

Authors:  Weiping Zou
Journal:  Nat Rev Cancer       Date:  2005-04       Impact factor: 60.716

2.  Critical role of CD4 T cells in maintaining lymphoid tissue structure for immune cell homeostasis and reconstitution.

Authors:  Ming Zeng; Mirko Paiardini; Jessica C Engram; Greg J Beilman; Jeffrey G Chipman; Timothy W Schacker; Guido Silvestri; Ashley T Haase
Journal:  Blood       Date:  2012-05-21       Impact factor: 22.113

3.  Interleukin 8: an autocrine growth factor for human ovarian cancer.

Authors:  L Xu; I J Fidler
Journal:  Oncol Res       Date:  2000       Impact factor: 5.574

4.  Fetal and adult hematopoietic stem cells give rise to distinct T cell lineages in humans.

Authors:  Jeff E Mold; Shivkumar Venkatasubrahmanyam; Trevor D Burt; Jakob Michaëlsson; Jose M Rivera; Sofiya A Galkina; Kenneth Weinberg; Cheryl A Stoddart; Joseph M McCune
Journal:  Science       Date:  2010-12-17       Impact factor: 47.728

5.  Reparixin, an inhibitor of CXCR1 and CXCR2 receptor activation, attenuates blood pressure and hypertension-related mediators expression in spontaneously hypertensive rats.

Authors:  Hye Young Kim; Jin Hee Choi; Young Jin Kang; So Young Park; Hyoung Chul Choi; Hee Sun Kim
Journal:  Biol Pharm Bull       Date:  2011       Impact factor: 2.233

6.  Vascular endothelial growth factor and interleukin-8 are associated with poor prognosis in epithelial ovarian cancer patients.

Authors:  Samar K Kassim; Eman M El-Salahy; Salah T Fayed; Sahar A Helal; Thanaa Helal; Ezz El-din Azzam; Ali Khalifa
Journal:  Clin Biochem       Date:  2004-05       Impact factor: 3.281

7.  Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.

Authors:  Tyler J Curiel; George Coukos; Linhua Zou; Xavier Alvarez; Pui Cheng; Peter Mottram; Melina Evdemon-Hogan; Jose R Conejo-Garcia; Lin Zhang; Matthew Burow; Yun Zhu; Shuang Wei; Ilona Kryczek; Ben Daniel; Alan Gordon; Leann Myers; Andrew Lackner; Mary L Disis; Keith L Knutson; Lieping Chen; Weiping Zou
Journal:  Nat Med       Date:  2004-08-22       Impact factor: 53.440

Review 8.  The interleukin-8 pathway in cancer.

Authors:  David J J Waugh; Catherine Wilson
Journal:  Clin Cancer Res       Date:  2008-11-01       Impact factor: 12.531

9.  PRC2 Epigenetically Silences Th1-Type Chemokines to Suppress Effector T-Cell Trafficking in Colon Cancer.

Authors:  Nisha Nagarsheth; Dongjun Peng; Ilona Kryczek; Ke Wu; Wei Li; Ende Zhao; Lili Zhao; Shuang Wei; Timothy Frankel; Linda Vatan; Wojciech Szeliga; Yali Dou; Scott Owens; Victor Marquez; Kaixiong Tao; Emina Huang; Guobin Wang; Weiping Zou
Journal:  Cancer Res       Date:  2015-11-13       Impact factor: 12.701

10.  Murine neonatal recent thymic emigrants are phenotypically and functionally distinct from adult recent thymic emigrants.

Authors:  Shannon J Opiela; Tulay Koru-Sengul; Becky Adkins
Journal:  Blood       Date:  2009-01-23       Impact factor: 22.113

View more
  6 in total

1.  FGF13 suppresses acute myeloid leukemia by regulating bone marrow niches.

Authors:  Ran Li; Kai Xue; Junmin Li
Journal:  Front Med       Date:  2022-09-02       Impact factor: 9.927

2.  The clinical implication of CD45RA+ naïve T cells and CD45RO+ memory T cells in advanced pancreatic cancer: a proxy for tumor biology and outcome prediction.

Authors:  Junjie Hang; Junjie Huang; Siyuan Zhou; Lixia Wu; Yingwei Zhu; Lina Zhu; Hanyu Zhou; Kequn Xu; Hua Jiang; Xuguang Yang
Journal:  Cancer Med       Date:  2019-02-14       Impact factor: 4.452

3.  BCL-2 expression promotes immunosuppression in chronic lymphocytic leukemia by enhancing regulatory T cell differentiation and cytotoxic T cell exhaustion.

Authors:  Lu Liu; Xianfeng Cheng; Hui Yang; Senlin Lian; Yuegen Jiang; Jinhua Liang; Xiao Chen; Suo Mo; Yu Shi; Sishu Zhao; Jianyong Li; Runqiu Jiang; Dong-Hua Yang; Yujie Wu
Journal:  Mol Cancer       Date:  2022-02-22       Impact factor: 27.401

4.  Construction of an Immune-Related lncRNA Signature That Predicts Prognosis and Immune Microenvironment in Osteosarcoma Patients.

Authors:  Yi He; Haiting Zhou; Haoran Xu; Hongbo You; Hao Cheng
Journal:  Front Oncol       Date:  2022-04-14       Impact factor: 5.738

Review 5.  High-throughput single-сell sequencing in cancer research.

Authors:  Qingzhu Jia; Han Chu; Zheng Jin; Haixia Long; Bo Zhu
Journal:  Signal Transduct Target Ther       Date:  2022-05-03

6.  CXCL8 is a potential biomarker for predicting disease progression in gastric carcinoma.

Authors:  Wen-Qian Qi; Qian Zhang; Jiang-Bin Wang
Journal:  Transl Cancer Res       Date:  2020-02       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.